Skip to content

    Cancer Health Center

    Font Size

    Late Effects of Treatment for Childhood Cancer (PDQ®): Treatment - Health Professional Information [NCI] - Late Effects of the Endocrine System

    Table 8. Anterior Pituitary Hormones and Major Hypothalamic Regulatory Factors continued...

    Adrenal-corticotropin deficiency

    Adrenocorticotropic hormone (ACTH) deficiency is less common than other neuroendocrine deficits but should be suspected in patients who have a history of brain tumor (regardless of therapy modality), cranial irradiation, GH deficiency, or central hypothyroidism.[22,24,49,53,54,55,56] Although uncommon, ACTH deficiency can occur in patients who have received intracranial radiation that did not exceed 24 Gy and has been reported to occur in less than 3% of patients after chemotherapy alone.[56] Patients with partial ACTH deficiency may have only subtle symptoms unless they become ill. Illness can disrupt these patients' usual homeostasis and cause a more severe, prolonged, or complicated course than expected. As in complete ACTH deficiency, incomplete or unrecognized ACTH deficiency can be life-threatening during concurrent illness.


    Hyperprolactinemia has been described in patients who have received doses of radiation higher than 50 Gy to the hypothalamus or who have undergone surgery disrupting the integrity of the pituitary stalk. Hyperprolactinemia may result in delayed puberty. In adult women, hyperprolactinemia may cause galactorrhea, menstrual irregularities, loss of libido, hot flashes, infertility, and osteopenia; in adult men, impotence and loss of libido. Primary hypothyroidism may lead to hyperprolactinemia as a result of hyperplasia of thyrotrophs and lactotrophs, presumably due to TRH hypersecretion. The prolactin response to TRH is usually exaggerated in these patients.[22,24,53]

    Table 9. Pituitary Gland Late Effects

    Predisposing Therapy Endocrine/Metabolic Effects Health Screening
    BMI = body mass index; FSH = follicle-stimulating hormone; LH = luteinizing hormone.
    Radiation impacting hypothalamic-pituitary axis Growth hormone deficiency Assessment of nutritional status
    Height, weight, BMI, Tanner stage
    Radiation impacting hypothalamic-pituitary axis Precocious puberty Height, weight, BMI, Tanner stage
    Radiation impacting hypothalamic-pituitary axis Gonadotropin deficiency History: puberty, sexual function
    Exam: Tanner stage
    FSH, LH, estradiol or testosterone levels
    Radiation impacting hypothalamic-pituitary axis Central adrenal insufficiency History: failure to thrive, anorexia, episodic dehydration, hypoglycemia, lethargy, unexplained hypotension
    Endocrine consultation for those with radiation dose ≥30 Gy
    Radiation impacting hypothalamic-pituitary axis Hyperprolactinemia History/exam: galactorrhea
    Prolactin level
    Radiation impacting hypothalamic-pituitary axis Overweight/obesity; metabolic syndrome Height, weight, BMI
    Blood pressure
    Fasting blood glucose level and lipid profile
    Radiation impacting hypothalamic-pituitary axis Central hypothyroidism Free thyroxine (Free T4) level
    1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12
    1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12
    Next Article:

    Today on WebMD

    man holding lung xray
    What you need to know.
    stem cells
    How they work for blood cancers.
    woman wearing pink ribbon
    Separate fact from fiction.
    Colorectal cancer cells
    Symptoms, screening tests, and more.
    Jennifer Goodman Linn self-portrait
    what is your cancer risk
    colorectal cancer treatment advances
    breast cancer overview slideshow
    prostate cancer overview
    lung cancer overview slideshow
    ovarian cancer overview slideshow
    Actor Michael Douglas